Showing results (1791-1800 of 1,907) with videos related to
Sort By:
Pageof 191
Science (New York, N.Y.)|June 6, 1998
Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genomeD G Wang, J B Fan, C J Siao, et al.The Journal of Urology|July 3, 2017
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial CarcinomaLaura-Maria Krabbe, Barbara Heitplatz, Sina Preuss, et al.Scientific Reports|December 23, 2017
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple MyelomaAllison E Drew, Oscar Moradei, Suzanne L Jacques, et al.Communications Biology|February 6, 2021
Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinomaMaeva Dufies, Annelies Verbiest, Lindsay S Cooley, et al.Clinics and Research in Hepatology and Gastroenterology|February 21, 2022
MiR-31-3p do not predict anti-EGFR efficacy in first-line therapy of RAS wild-type metastatic right-sided colon cancerEmeric Boisteau, Alexandra Lespagnol, Marie De Tayrac, et al.ACS Medicinal Chemistry Letters|August 27, 2016
Aligning Potency and Pharmacokinetic Properties for Pyridine-Based NCINIsLee D Fader, Murray Bailey, Eric Beaulieu, et al.Human Molecular Genetics|December 28, 2018
Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II allelesFrauke Degenhardt, Mareike Wendorff, Michael Wittig, et al.Science Translational Medicine|September 27, 2019
Lrrk2 alleles modulate inflammation during microbial infection of mice in a sex-dependent mannerBojan Shutinoski, Mansoureh Hakimi, Irene E Harmsen, et al.Genes and Immunity|June 1, 2007
The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseasesP L De Jager, D Franchimont, A Waliszewska, et al.Genes and Immunity|March 7, 2014
MHC associations with clinical and autoantibody manifestations in European SLED L Morris, M M A Fernando, K E Taylor, et al.Pageof 191